Molecular BiologybioRxivPreprint
Genome-Wide CRISPR-Cas9 Screening Identifies a Synergy between Hypomethylating Agents and SUMOylation Blockade in MDS/AML
Peter Truong, Sylvie Shen, Swapna Mahurkar Joshi…·John E. Pimanda
This study identifies a synergy between hypomethylating agents and SUMOylation blockade in MDS/AML using CRISPR-Cas9 screening, showing improved therapeutic outcomes in xenograft models.
DOI 10.1101/2024.04.17.589858